August 2026
Dymista
azelastine hydrochloride and fluticasone propionate
Spray, metered (nasal) · NDA 202236
Last listed protection ended
August 24, 2026
The FDA listed 1 patent for Dymista, and this is the day the last one ended. It is not the date a generic goes on sale.
Patents and exclusivities
- EndedPatent 8,168,620Claims the drug product
- EndedPatent 8,168,620Pediatric extension: six more months